Insight into the molecular mechanism of the transposon-encoded type I-F CRISPR-Cas system

Jansen R, Van Embden JDA, Gaastra W, Schouls LM. Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol 2002;43. https://doi.org/10.1046/j.1365-2958.2002.02839.x. Mojica FJM, Díez-Villaseñor C, Soria E, Juez G. Biological significance of a family of regularly spaced repeats in the genomes of Archaea, Bacteria and mitochondria. Mol Microbiol 2000;36. https://doi.org/10.1046/j.1365-2958.2000.01838.x. Makarova KS, Wolf YI, Koonin E V. Classification and Nomenclature of CRISPR-Cas Systems: Where from Here? Cris J 2018;1. https://doi.org/10.1089/crispr.2018.0033. Makarova KS, Wolf YI, Alkhnbashi OS, Costa F, Shah SA, Saunders SJ, et al. An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol 2015;13. https://doi.org/10.1038/nrmicro3569. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816–21. https://doi.org/10.1126/science.1225829. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. Multiplex genome engineering using CRISPR-Cas systems. Science (80- ) 2013;339. https://doi.org/10.1126/science.1231143. Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 2013;31. https://doi.org/10.1038/nbt.2647. Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 2013;31. https://doi.org/10.1038/nbt.2623. Jasin M, Haber JE. The democratization of gene editing: Insights from site-specific cleavage and double-strand break repair. DNA Repair (Amst) 2016;44. https://doi.org/10.1016/j.dnarep.2016.05.001. Klompe SE, Sternberg SH (2018) Harnessing “A billion years of experimentation”: The ongoing exploration and exploitation of CRISPR–Cas Immune Systems. Cris J 1:141–158. https://doi.org/10.1089/crispr.2018.0012 Peters JE, Makarova KS, Shmakov S, Koonin EV (2017) Recruitment of CRISPR-Cas systems by Tn7-like transposons. Proc Natl Acad Sci U S A 114:E7358–E7366. https://doi.org/10.1073/pnas.1709035114 Klompe SE, Vo PLH, Halpin-Healy TS, Sternberg SH (2019) Transposon-encoded CRISPR–Cas systems direct RNA-guided DNA integration. Nature 571:219–225. https://doi.org/10.1038/s41586-019-1323-z Strecker J, Ladha A, Gardner Z, Schmid-Burgk JL, Makarova KS, Koonin EV et al (2019) RNA-guided DNA insertion with CRISPR-associated transposases. Science (80-). 364:48–53. https://doi.org/10.1126/science.aax9181 Kwon JB, Gersbach CA. Jumping at the chance for precise DNA integration. Nat Biotechnol 2019:4–5. https://doi.org/10.1038/s41587-019-0210-3. Halpin-Healy TS, Klompe SE, Sternberg SH, Fernández IS (2020) Structural basis of DNA targeting by a transposon-encoded CRISPR–Cas system. Nature 577:271–274. https://doi.org/10.1038/s41586-019-1849-0 Koonin E V, Makarova KS. CRISPR-Cas: an adaptive immunity system in prokaryotes. F1000 Biol Rep 2009;1. https://doi.org/10.3410/b1-95. van der Oost J, Jore MM, Westra ER, Lundgren M, Brouns SJJ. CRISPR-based adaptive and heritable immunity in prokaryotes. Trends Biochem Sci 2009;34. https://doi.org/10.1016/j.tibs.2009.05.002. Hidalgo-Cantabrana C, Goh YJ, Barrangou R. Characterization and Repurposing of Type I and Type II CRISPR–Cas Systems in Bacteria. J Mol Biol 2019;431. https://doi.org/10.1016/j.jmb.2018.09.013. Zheng Y, Li J, Wang B, Han J, Hao Y, Wang S et al (2020) Endogenous Type I CRISPR-Cas: From Foreign DNA Defense to Prokaryotic Engineering. Front Bioeng Biotechnol 8:1–17. https://doi.org/10.3389/fbioe.2020.00062 McDonald ND, Regmi A, Morreale DP, Borowski JD, Fidelma BE (2019) CRISPR-Cas systems are present predominantly on mobile genetic elements in Vibrio species. BMC Genomics 20:1–23. https://doi.org/10.1186/s12864-019-5439-1 Hille F, Richter H, Wong SP, Bratovič M, Ressel S, Charpentier E (2018) The Biology of CRISPR-Cas: Backward and Forward. Cell 172:1239–1259. https://doi.org/10.1016/j.cell.2017.11.032 Brouns SJJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJH, Snijders APL, et al. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science (80- ) 2008;321. https://doi.org/10.1126/science.1159689. Chylinski K, Le Rhun A, Charpentier E. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems. RNA Biol 2013;10. https://doi.org/10.4161/rna.24321. Fonfara I, Le Rhun A, Chylinski K, Makarova KS, Lécrivain AL, Bzdrenga J, et al. Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems. Nucleic Acids Res 2014;42. https://doi.org/10.1093/nar/gkt1074. Torres-Ruiz R, Rodriguez-Perales S. CRISPR-Cas9: A revolutionary tool for cancer modelling. Int J Mol Sci 2015;16. https://doi.org/10.3390/ijms160922151. Frangoul H, Altshuler D, Cappellini MD, Chen Y-S, Domm J, Eustace BK, et al. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. N Engl J Med 2021;384. https://doi.org/10.1056/nejmoa2031054. Shmakov S, Abudayyeh OO, Makarova KS, Wolf YI, Gootenberg JS, Semenova E, et al. Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems. Mol Cell 2015;60. https://doi.org/10.1016/j.molcel.2015.10.008. Abudayyeh OO, Gootenberg JS, Konermann S, Joung J, Slaymaker IM, Cox DBT, et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science (80- ) 2016;353. https://doi.org/10.1126/science.aaf5573. Lee JG, Ha CH, Yoon B, Cheong SA, Kim G, Lee DJ, et al. Knockout rat models mimicking human atherosclerosis created by Cpf1-mediated gene targeting. Sci Rep 2019;9. https://doi.org/10.1038/s41598-019-38732-2. Peters JE. Tn7 30. Microbiol Spectr 2014;2. https://doi.org/10.1128/microbiolspec. MDNA3–0010–2014. Dieci G, Fiorino G, Castelnuovo M, Teichmann M, Pagano A. The expanding RNA polymerase III transcriptome. Trends Genet 2007;23. https://doi.org/10.1016/j.tig.2007.09.001. Gringauz E, Orle KA, Waddell CS, Craig NL. Recognition of Escherichia coli attTn7 by transposon Tn7: lack of specific sequence requirements at the point of Tn7 insertion. J Bacteriol 1988;170. https://doi.org/10.1128/jb.170.6.2832-2840.1988. McKown RL, Orle KA, Chen T, Craig NL. Sequence requirements of Escherichia coli attTn7, a specific site of transposon Tn7 insertion. J Bacteriol 1988;170. https://doi.org/10.1128/jb.170.1.352-358.1988. Lichtenstein C, Brenner S. Unique insertion site of Tn7 in the E. coli chromosome. Nature 1982;297. https://doi.org/10.1038/297601a0. Waddell CS, Craig NL. Tn7 transposition: two transposition pathways directed by five Tn7-encoded genes. Genes Dev 1988;2. https://doi.org/10.1101/gad.2.2.137. Wolkow CA, DeBoy RT, Craig NL. Conjugating plasmids are preferred targets for Tn7. Genes Dev 1996;10. https://doi.org/10.1101/gad.10.17.2145. Haren L, Ton-Hoang B, Chandler M. Integrating DNA: Transposases and retroviral integrases. Annu Rev Microbiol 1999;53. https://doi.org/10.1146/annurev.micro.53.1.245. Sarnovsky RJ, May EW, Craig NL. The Tn7 transposase is a heteromeric complex in which DNA breakage and joining activities are distributed between different gene products. EMBO J 1996;15. https://doi.org/10.1002/j.1460-2075.1996.tb01024.x. Parks AR, Peters JE. Tn7 elements: Engendering diversity from chromosomes to episomes. Plasmid 2009;61. https://doi.org/10.1016/j.plasmid.2008.09.008. Mitra R, McKenzie GJ, Yi L, Lee CA, Craig NL (2010) Characterization of the TnsD-attTn7 complex that promotes site-specific insertion of Tn7. Mob DNA 1:1–14. https://doi.org/10.1186/1759-8753-1-18 Parks AR, Peters JE. Transposon Tn7 is widespread in diverse bacteria and forms genomic islands. J Bacteriol 2007;189. https://doi.org/10.1128/JB.01536-06. Jia N, Xie W, de la Cruz MJ, Eng ET, Patel DJ (2020) Structure–function insights into the initial step of DNA integration by a CRISPR–Cas–Transposon complex. Cell Res 30:182–184. https://doi.org/10.1038/s41422-019-0272-2 Shen Y, Gomez-Blanco J, Petassi MT, Peters JE, Ortega J, Guarné A (2022) Structural basis for DNA targeting by the Tn7 transposon. Nat Struct Mol Biol 29:143–151. https://doi.org/10.1038/s41594-022-00724-8 Li Z, Zhang H, Xiao R, Chang L (2020) Cryo-EM structure of a type I-F CRISPR RNA guided surveillance complex bound to transposition protein TniQ. Cell Res 30:179–181. https://doi.org/10.1038/s41422-019-0268-y Wang B, Xu W, Yang H (2020) Structural basis of a Tn7-like transposase recruitment and DNA loading to CRISPR-Cas surveillance complex. Cell Res 30:185–187. https://doi.org/10.1038/s41422-020-0274-0 Vo PLH, Ronda C, Klompe SE, Chen EE, Acree C, Wang HH et al (2021) CRISPR RNA-guided integrases for high-efficiency, multiplexed bacterial genome engineering. Nat Biotechnol 39:480–489. https://doi.org/10.1038/s41587-020-00745-y Liu TY, Doudna JA (2020) Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation. J Biol Chem 295:14473–14487. https://doi.org/10.1074/jbc.REV120.007034 Vo PLH, Acree C, Smith ML, Sternberg SH (2021) Unbiased profiling of CRISPR RNA-guided transposition products by long-read sequencing. Mob DNA 12:4–11. https://doi.org/10.1186/s13100-021-00242-2 Rybarski JR, Hu K, Hill AM, Wilke CO, Finkelstein IJ (2021) Metagenomic discovery of CRISPR-associated transposons. Proc Natl Acad Sci U S A 118:1–13. https://doi.org/10.1073/pnas.2112279118 Mohanraju P, Makarova KS, Zetsche B, Zhang F, Koonin E V., Van Der Oost J. Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems. Science (80- ) 2016;353. https://doi.org/10.1126/science.aad5147. Charpentier E, Richter H, van der Oost J, White MF. Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity. FEMS Microbiol Rev 2015;39. https://doi.org/10.1093/femsre/fuv023. Sternberg SH, Haurwitz RE, Doudna JA. Mechanism of substrate selection by a highly specific CRISPR endoribonuclease. RNA 2012;18. https://doi.org/10.1261/rna.030882.111. Haurwitz RE, Jinek M, Wiedenheft B, Zhou K, Doudna JA. Sequence- and structure-specific RNA processing by a CRISPR endonuclease. Science (80- ) 2010;329. https://doi.org/10.1126/science.1192272. Jore MM, Lundgren M, Van Duijn E, Bultema JB, Westra ER, Waghmare SP, et al. Structural basis for CRISPR RNA-guided DNA recognition by Cascade. Nat Struct Mol Biol 2011;18. https://doi.org/10.1038/nsmb.2019. DeLano WL. The PyMOL Molecular Graphics System, Version 2.3. Schrödinger LLC 2020. Wiedenheft B, Lander GC, Zhou K, Jore MM, Brouns SJJ, Van Der Oost J, et al. Structures of the RNA-guided surveillance complex from a bacterial immune system. Nature 2011;477. https://doi.org/10.1038/nature10402. Kuduvalli PN, Rao JE, Craig NL (2001) Target DNA structure plays a critical role in Tn7 transposition. EMBO J 20:924–932. https://doi.org/10.1093/emboj/20.4.924 Bainton RJ, Kubo KM, Feng J nong, Craig NL. Tn7 transposition: Target DNA recognition is mediated by multiple Tn7-encoded proteins in a purified in vitro system. Cell 1993;72. https://doi.org/10.1016/0092-8674(93)90581-A. Laity JH, Lee BM, Wright PE. Zinc finger proteins: New insights into structural and functional diversity. Curr Opin Struct Biol 2001;11. https://doi.org/10.1016/S0959-440X(00)00167-6. Flores C, Qadri MI, Lichtenstein C. DNA sequence analysis of five genes; tnsA, B, C, D and E, required for Tn7 transposition. Nucleic Acids Res 1990;18. https://doi.org/10.1093/nar/18.4.901. Stellwagen AE, Craig NL (1997) Gain-of-function mutations in TnsC, an ATP-dependent transposition protein that activates the bacterial transposon Tn7. Genetics 145:573–585. https://doi.org/10.1093/genetics/145.3.573 Ronning DR, Li Y, Perez ZN, Ross PD, Hickman AB, Craig NL et al (2004) The carboxy-terminal portion of TnsC activates the Tn7 transposase through a specific interaction with TnsA. EMBO J 23:2972–2981. https://doi.org/10.1038/sj.emboj.7600311 Rao JE, Miller PS, Craig NL. Recognition of triple-helical DNA structures by transposon Tn7. Proc Natl Acad Sci U S A 2000;97. https://doi.org/10.1073/pnas.080061497. Park JU, Tsai AWL, Mehrotra E, Petassi MT, Hsieh SC, Ke A et al (2021) Structural basis for target site selection in RNA-guided DNA transposition systems. Science (80-). 373:768–74. https://doi.org/10.1126/science.abi8976 Robinson MK, Bennett PM, Richmond MH. Inhibition of TnA translocation by TnA. J Bacteriol 1977;129. https://doi.org/10.1128/jb.129.1.407-414.1977. Arciszewska LK, Drake D, Craig NL. Transposon Tn7. cis-Acting sequences in transposition and transposition immunity. J Mol Biol 1989;207. https://doi.org/10.1016/0022-2836(89)90439-7. Hickman AB, Li Y, Mathew SV, May EW, Craig NL, Dyda F (2000) Unexpected structural diversity in DNA recombination: The restriction endonuclease connection. Mol Cell 5:1025–1034. https://doi.org/10.1016/S1097-2765(00)80267-1 Harrison SC, Aggarwal AK. DNA recognition by proteins with the helix-turn-helix motif. Annu Rev Biochem 1990;59. https://doi.org/10.1146/annurev.bi.59.070190.004441. Stellwagen AE, Craig NL. Analysis of gain-of-function mutants of an ATP-dependent regulator of Tn7 transposition. J Mol Biol 2001;305. https://doi.org/10.1006/jmbi.2000.4317. Hare S, Gupta SS, Valkov E, Engelman A, Cherepanov P. Retroviral intasome assembly and inhibition of DNA strand transfer. Nature 2010;464. https://doi.org/10.1038/nature08784. Zheng R, Jenkins TM, Craigie R. Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proc Natl Acad Sci U S A 1996;93. https://doi.org/10.1073/pnas.93.24.13659. Hare S, Maertens GN, Cherepanov P. 3′-Processing and strand transfer catalysed by retroviral integrase in crystallo. EMBO J 2012;31. https://doi.org/10.1038/emboj.2012.118. Kvaratskhelia M, Sharma A, Larue RC, Serrao E, Engelman A (2014) Molecular mechanisms of retroviral integration site selection. Nucleic Acids Res 42:10209–10225. https://doi.org/10.1093/nar/gku769 Dyda F, Hickman AB, Jenkins TM, Engelman A, Craigie R, Davies DR (1994) Crystal structure of the catalytic domain of HIV-1 integrase: Similarity to other polynucleotidyl transferases. Science (80-) 266:1981–6. https://doi.org/10.1126/science.7801124 Choi KY, Spencer JM, Craig NL (2014) The Tn7 transposition regulator TnsC interacts with the transposase subunit TnsB and target selector TnsD. Proc Natl Acad Sci U S A 111:2858–2865. https://doi.org/10.1073/pnas.1409869111 McKown RL, Waddell CS, Arciszewska LK, Craig NL. Identification of a transposon Tn7-dependent DNA-binding activity that recognizes the ends of Tn7. Proc Natl Acad Sci U S A 1987;84. https://doi.org/10.1073/pnas.84.22.7807. May EW, Craig NL. Switching from cut-and-paste to replicative Tn7 transposition. Science (80- ) 1996;272. https://doi.org/10.1126/science.272.5260.401. Arciszewska LK, Craig NL (1991) Interaction of the Tn7-encoded transposition protein TnsB with the ends of the transposon. Nucleic Acids Res 19:5021–5029. https://doi.org/10.1093/nar/19.18.5021 Peters JE, Fricker AD, Kapili BJ, Petassi MT (2014) Heteromeric transposase elements: Generators of genomic Islands across diverse bacteria. Mol Microbiol 93:1084–1092. https://doi.org/10.1111/mmi.12740 Biery MC, Lopata M, Craig NL. A minimal system for Tn7 transposition: The transposon-encoded proteins TnsA and TnsB can execute DNA breakage and joining reactions that generate circularized Tn7 species. J Mol Biol 2000;297. https://doi.org/10.1006/jmbi.2000.3558. Choi KY, Li Y, Sarnovsky R, Craig NL. Direct interaction between the TnsA and TnsB subunits controls the heteromeric Tn7 transposase. Proc Natl Acad Sci U S A 2013;110. https://doi.org/10.1073/pnas.1305716110. Rubin BE, Diamond S, Cress BF, Crits-Christoph A, He C, Xu M, et al. Targeted genome editing of bacteria within microbial communities. BioRxiv 2020:1–49. https://doi.org/10.1101/2020.07.17.209189.